Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-13-025073
Filing Date
2013-05-03
Accepted
2013-05-03 16:04:36
Documents
1
Period of Report
2013-05-01

Document Format Files

Seq Description Document Type Size
1 rrd378053.html 4  
1 rrd378053.xml 4 3959
  Complete submission text file 0001181431-13-025073.txt   5297
Mailing Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710
Business Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710 5108485100
DYNAVAX TECHNOLOGIES CORP (Issuer) CIK: 0001029142 (see all company filings)

EIN.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710
Business Address
Gray Eddie (Reporting) CIK: 0001575349 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34207 | Film No.: 13812644